Evidence map›Paper›PMID 36620664›Full record

ArticleFrontiers in psychiatry2022

Development of medical device software for the screening and assessment of depression severity using data collected from a wristband-type wearable device: SWIFT study protocol.

Taishiro Kishimoto, Shotaro Kinoshita, Toshiaki Kikuchi, Shogyoku Bun, Momoko Kitazawa, Toshiro Horigome, Yuki Tazawa, Akihiro Takamiya, Jinichi Hirano, Masaru Mimura and 12 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in psychiatry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. The now and future of ChatGPT and GPT in psychiatry.Psychiatry and clinical neurosciences · 2023
    Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 6 institutions in 1 country.

Taishiro KishimotoHills Joint Research Laboratory for Future Preventive Medicine and Wellness, Keio University School of Medicine, Tokyo, Japan.
Shotaro KinoshitaHills Joint Research Laboratory for Future Preventive Medicine and Wellness, Keio University School of Medicine, Tokyo, Japan.
Toshiaki KikuchiDepartment of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Shogyoku BunDepartment of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Momoko KitazawaDepartment of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Toshiro Horigomei2medical LLC, Kawasaki, Japan.
Yuki Tazawai2medical LLC, Kawasaki, Japan.
Akihiro TakamiyaDepartment of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Jinichi HiranoDepartment of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Masaru MimuraDepartment of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Kuo-Ching Liangi2medical LLC, Kawasaki, Japan.
Norihiro Kogai2medical LLC, Kawasaki, Japan.
Yasushi OchiaiFrontier Business Office, Sumitomo Pharma Co., Ltd., Tokyo, Japan.
Hiromi ItoFrontier Business Office, Sumitomo Pharma Co., Ltd., Tokyo, Japan.
Yumiko MiyamaeFrontier Business Office, Sumitomo Pharma Co., Ltd., Tokyo, Japan.
Yuiko TsujimotoFrontier Business Office, Sumitomo Pharma Co., Ltd., Tokyo, Japan.
Kei SakumaAsaka Hospital, Koriyama, Japan.
Hisashi KidaDepartment of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Gentaro MiuraOizumi Hospital, Tokyo, Japan.
Yuko KawadeDepartment of Psychiatry, Tsurugaoka Garden Hospital, Tokyo, Japan.
Akiko GotoDepartment of Psychiatry, Tsurugaoka Garden Hospital, Tokyo, Japan.
Fumihiro YoshinoDepartment of Psychiatry, Tsurugaoka Garden Hospital, Tokyo, Japan.
Keio University · JPSumitomo Dainippon Pharma (Japan) · JPMunicipal Tsuruga Hospital · JPAzumi Hospital · JPSatou Hospital · JPTokyo University of Information Sciences · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Few biomarkers can be used clinically to diagnose and assess the severity of depression. However, a decrease in activity and sleep efficiency can be observed in depressed patients, and recent technological developments have made it possible to measure these changes. In addition, physiological changes, such as heart rate variability, can be used to distinguish depressed patients from normal persons; these parameters can be used to improve diagnostic accuracy. The proposed research will explore and construct machine learning models capable of detecting depressive episodes and assessing their severity using data collected from wristband-type wearable devices. Methods and analysis: Patients with depressive symptoms and healthy subjects will wear a wristband-type wearable device for 7 days; data on triaxial acceleration, pulse rate, skin temperature, and ultraviolet light will be collected. On the seventh day of wearing, the severity of depressive episodes will be assessed using Structured Clinical Interview for DSM-5 (SCID-5), Hamilton Depression Rating Scale (HAMD), and other scales. Data for up to five 7-day periods of device wearing will be collected from each subject. Using wearable device data associated with clinical symptoms as supervisory data, we will explore and build a machine learning model capable of identifying the presence or absence of depressive episodes and predicting the HAMD scores for an unknown data set. Discussion: Our machine learning model could improve the clinical diagnosis and management of depression through the use of a wearable medical device. Clinical trial registration: [https://jrct.niph.go.jp/latest-detail/jRCT1031210478], identifier [jRCT1031210478].

Indexed as

depressiondigital healthmachine learningpersonalized medicinewearables

Identifiers

PMID36620664
PMCPMC9811592
OpenAlexW4313466998

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.